HOME
THE COMPANY
PIPELINE
RESEARCH
INVESTOR RELATIONS
NEWS
CONTACT
Welcome to Hansa Medical
Hansa Medical is a research company focused on development of biopharmaceuticals and diagnostics within inflammation. Biopharma and diagnostics development at Hansa Medical is based on the molecular interplay between the immune system and pathogenic bacteria.
Hansa Medical develops the enzymes IdeS and EndoS towards therapeutic applications within rare autoimmune diseases and organ transplantation. Also, the company develops a clinical-stage diagnostic method, HMD-301, for the prognosis and diagnosis of severe sepsis.
Latest News
Hansa Medical secures MSEK 46 for performing Phase 1 and Phase 2 clinical trials with IdeS within transplantation.
More information.
Press Releases
2012-01-25
Directed new share issue by Hansa Medical AB (publ) completed
2012-01-10
Bulletin from the Extraordinary General Meeting of Hansa Medical AB (publ)
2011-12-14
Notice of extraordinary meeting of shareholders in Hansa Medical AB (publ)
See archive
The Share
2012-JAN-27
+/-%
Latest
Buy
Sell
HMED
-5.94%
4.75
4.75
4.95